We are live on ! Find out more
LS

Leelyn Smith Portfolio holdings

AUM $822M Turnover 11.52%
1-Year Est. Return 31.69%
This Fund
S&P 500
This Quarter Est. Return
+16.11%
1 Year Est. Return
+31.69%
3 Year Est. Return
+77.34%
5 Year Est. Return
+91.98%
10 Year Est. Return
–
AUM
$243M
AUM Growth
+$55.2M
Cap. Flow
+$46.5M
Cap. Flow %
19.17%
Top 10 Hldgs %
43.97%
Holding
439
New
112
Increased
115
Reduced
72
Closed
39
Avg Time Held
0.3 years
Top 10 Avg Time Held
0.4 years
Top 20 Avg Time Held
0.4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 53.95%
2 Technology 9.37%
3 Consumer Discretionary 6.6%
4 Industrials 5.97%
5 Consumer Staples 5.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TMUSR icon
351
DELISTED
T-Mobile US, Inc. Subscription Rights Expiring 7/27/2020
TMUSR
$0 ﹤0.01%
+2,105
New +$591
2020 Q2
0 quarters
RTN
352
DELISTED
Raytheon Company
RTN
– –
-35
Closed -$5K –
ADRE
353
DELISTED
Invesco BLDRS Emerging Markets 50 ADR Index Fund
ADRE
– –
-376
Closed -$13K –
FTR
354
DELISTED
Frontier Communications Corp.
FTR
– –
-2
Closed – –
SLY icon
355
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
– –
-146
Closed -$7K –

Similar funds

Leelyn Smith's Q2 2020 Portfolio in Review

As of Q2 2020, Leelyn Smith held 439 positions worth $243M, up 29% from $187M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Leelyn Smith deployed $46.5M of net new capital in Q2 2020, opening 112 new positions and adding to 115 existing holdings. Its largest new stake was First Trust NYSE Arca Biotechnology Index Fund: 1,814 shares worth $304K.

By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Clorox, an estimated $2.22M trimmed.

  • Leelyn Smith's largest Q2 2020 buy was First Trust NYSE Arca Biotechnology Index Fund: 1,814 shares worth $304K.
  • Leelyn Smith added most to 3M in Q2 2020, an estimated $24.2M increase.
  • Leelyn Smith's biggest Q2 2020 reduction was Clorox, cutting an estimated $2.22M.
  • Leelyn Smith fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, selling an estimated $333K.
  • Leelyn Smith's ten largest holdings make up 44% of its $243M portfolio in Q2 2020.
  • Leelyn Smith opened 112 new positions and closed 39 in Q2 2020.
  • Leelyn Smith's portfolio value rose 29% quarter-over-quarter to $243M.

Based on Leelyn Smith's 13F filing for Q2 2020, filed 6 Aug 2020.